Oct 19, 2026 03:15AM
Oct 1, 2026 03:15AM
Sep 29, 2026 03:16AM
Sep 29, 2026 03:15AM
Sep 28, 2026 05:00PM
Sep 8, 2026 06:13AM
Sep 8, 2026 03:15AM Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders
Sep 4, 2026 06:00PM
Aug 31, 2026 03:15AM
Aug 17, 2026 03:17AM
Aug 17, 2026 03:15AM
Aug 4, 2026 03:17AM
Aug 4, 2026 03:15AM
Jul 8, 2026 03:15AM Defence Therapeutics Opens New Office in Hamilton to Expand Its Accum Radiopharmaceutical Platform
Jun 17, 2026 03:17AM
Jun 17, 2026 03:15AM
Jun 3, 2026 03:17AM
Jun 3, 2026 03:15AM
Jun 1, 2026 03:17AM
Jun 1, 2026 03:15AM
May 29, 2026 04:32PM Defence Therapeutics appoints Dr. Sarkis Meterissian to advisory board
May 29, 2026 04:30PM
May 19, 2026 03:15AM
Apr 24, 2026 06:30PM
Mar 20, 2026 06:00PM
Mar 9, 2026 03:17AM
Mar 9, 2026 03:15AM
Mar 2, 2026 03:15AM Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March
Feb 27, 2026 05:02PM
Feb 27, 2026 05:00PM
Feb 10, 2026 03:17AM
Feb 10, 2026 03:15AM
Feb 4, 2026 03:15AM
Jan 28, 2026 08:40AM
Jan 21, 2026 03:15AM Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
Dec 10, 2025 04:30PM
Dec 4, 2025 03:17AM
Dec 4, 2025 03:15AM
Nov 21, 2025 06:03PM
Nov 19, 2025 03:15AM
Nov 6, 2025 03:15AM
Nov 4, 2025 03:15AM Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models
Oct 23, 2025 03:15AM
Oct 6, 2025 03:15AM
Oct 2, 2025 03:15AM
Sep 23, 2025 09:15AM
Sep 16, 2025 03:17AM
Sep 16, 2025 03:15AM
Sep 15, 2025 04:30PM Defence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000
Sep 2, 2025 03:15AM

467,012 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All